PlainRecalls
FDA Drug Moderate Class II Terminated

Lidocaine HCl/Phenylephrine HCl Nasal Solution, 4%/1%, 240 mL per bottle, Multiple Dose Container, Edge Pharma, LLC 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1045-03

Reported: February 2, 2022 Initiated: December 6, 2021 #D-0444-2022

Product Description

Lidocaine HCl/Phenylephrine HCl Nasal Solution, 4%/1%, 240 mL per bottle, Multiple Dose Container, Edge Pharma, LLC 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1045-03

Reason for Recall

CGMP Deviations

Details

Recalling Firm
Edge Pharma, LLC
Units Affected
231 bottles
Distribution
nationwide
Location
Colchester, VT

Frequently Asked Questions

What product was recalled?
Lidocaine HCl/Phenylephrine HCl Nasal Solution, 4%/1%, 240 mL per bottle, Multiple Dose Container, Edge Pharma, LLC 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1045-03. Recalled by Edge Pharma, LLC. Units affected: 231 bottles.
Why was this product recalled?
CGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on February 2, 2022. Severity: Moderate. Recall number: D-0444-2022.